‹All articlesMedia Stories

The Economist: Would You Risk a Breakdown to Cure Baldness?

The Economist's Brooke Masters on the hair-loss industry, the side effects it plays down, and why finasteride risks stay out of the marketing.

By Morten SkovPublished Updated

This is coverage by another outlet. We link to it because it reports on PFS, PSSD or PAS — the reporting and any views in it are the publisher's, not ours.

The Economist: Would You Risk a Breakdown to Cure Baldness?

In a compelling piece for The Economist, writer Brooke Masters delves into the controversial world of hair-loss treatments and their often overlooked side effects. From the allure of a full head of hair to the devastating risks, discover the untold stories and critical insights into a booming industry. Don’t miss this eye-opening read.

Read the full article on The Economist

The Devastating Impact of Propecia – How Finasteride is Ruining Thousands of Lives

Millions take Finasteride worldwide, unaware of its devastating effects on male health. Marketed as a “safe” hair loss solution, pharmaceutical companies and telehealth providers downplay the risks, keeping consumers in the dark. This lack of transparency leaves thousands of men struggling with the life-altering consequences of this drug. The number of victims is growing everyday.

Learn the truth about Propecia

This information does not replace medical advice. Talk to your doctor before you make any decision about your treatment.

PFS, PSSD, PAS Registry

570+ people have joined the registry.
Join them, then report your side effects.

  • Put your condition on the record
  • Be first to hear about studies you can join
  • Then report your side effects to your regulator
Live 570+ people counted so far Each dot is one person 62countries 3conditions
If you are in crisis: 116 123 Samaritans (UK)988 Lifeline (US)Find a helpline

PFS, PSSD, PAS Registry

570+ people have joined the registry. Join them.

3 minutes to sign up · Information never shared